Literature DB >> 12752731

Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies.

Pertti Marnila1, Susanna Rokka, Leena Rehnberg-Laiho, Päivi Kärkkäinen, Timo U Kosunen, Hilpi Rautelin, Marja-Liisa Hänninen, Eeva-Liisa Syväoja, Hannu Korhonen.   

Abstract

BACKGROUND: Specific antibodies against Helicobacter were enriched from the colostra of hyperimmunized cows. Efficacies of colostral control preparation and immune preparation containing specific antibodies against Helicobacter felis were studied in the prevention and treatment of experimental H. felis infection in mice.
MATERIALS AND METHODS: H. felis-infected mice were given either immune or control preparation with or without complement or amoxicillin orally in four different trials. H. felis status was assessed on the basis of bacterial stainings, gastric histology and serum antibodies.
RESULTS: Immune, but not control preparation, prevented H. felis infection (p > 0.01), the efficacy being dependent on the presence of specific antibodies. In the trial on infected Balb/c mice treatment with immune preparation (p = 0.029) but not control preparation decreased the colonization of gastric antrum by H. felis. In the further trials with infected SJL-mice, treatments with colostral preparations did not decrease colonization. Amoxicillin treatment decreased the colonization with trend-setting significance (p = 0.056; infected mice as controls), whereas amoxicillin combined with immune preparation had a significant effect (p < 0.0005).
CONCLUSIONS: Specific colostral antibodies were useful in the prevention of Helicobacter infection in a mouse model. The results of the treatment trials were controversial but a similar colostral immune preparation against H. pylori could be effective and useful in preventing infections in humans and during antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752731     DOI: 10.1046/j.1523-5378.2003.00144.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  8 in total

Review 1.  Bioactive peptides and proteins from foods: indication for health effects.

Authors:  Niels Peter Möller; Katharina Elisabeth Scholz-Ahrens; Nils Roos; Jürgen Schrezenmeir
Journal:  Eur J Nutr       Date:  2008-05-27       Impact factor: 5.614

Review 2.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 3.  The Helicobacter felis model of adoptive transfer gastritis.

Authors:  Vance J McCracken; Steven M Martin; Robin G Lorenz
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Bovine antibody-based oral immunotherapy for reduction of intragastric Helicobacter pylori colonization: a randomized clinical trial.

Authors:  Caroline Maria den Hoed; A C de Vries; P B F Mensink; C M Dierikx; H Suzuki; L Capelle; H van Dekken; R Ouwendijk; E J Kuipers
Journal:  Can J Gastroenterol       Date:  2011-04       Impact factor: 3.522

5.  Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity.

Authors:  Rebecca J Gorrell; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

Review 6.  Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.

Authors:  Aleksandra Sokic-Milutinovic; Tamara Alempijevic; Tomica Milosavljevic
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

7.  The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial.

Authors:  Dailun Hu; Feng Zhang; Jikun Zhou; Baohong Xu; Hongying Zhang; Huiqin Qiang; Shuguang Ren; Baoen Shan; Changfu Yin; Zhitao Zhang; Xian Wang; Chuan Zhao; Zhongli Shi
Journal:  J Transl Med       Date:  2015-06-30       Impact factor: 5.531

Review 8.  Milk immunoglobulins for health promotion.

Authors:  Raj Mehra; Pertti Marnila; Hannu Korhonen
Journal:  Int Dairy J       Date:  2006-08-21       Impact factor: 3.032

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.